Emapalumab (anti-IFNγ)

Catalog No.A2041        Batch: A204102

Print

Technical Data

CAS No. 1709815-23-5
Formulation PBS Buffer, PH 7.4
Isotype Human IgG1
Application Emapalumab (anti-IFNγ)
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Purity 98%
Protein concentration 3.6mg/ml
Endotoxin Level <1EU/mg

Biological Activity

Description Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.

Selleck's Emapalumab (anti-IFNγ) has been cited by 1 publication

Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma [ Blood Adv, 2024, bloodadvances.2023012522] PubMed: 39058976

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.